Showing results (161-170 of 173) with videos related to
Sort By:
Pageof 18
Blood|January 29, 2021
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL familiesSusan L Slager, Mark C Lanasa, Gerald E Marti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 6, 2023
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemiaS H Cass, J W D Tobin, Y D Seo, et al.Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.Blood|April 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variantClive S Zent, Enrico Tiacci, Robert J Kreitman, et al.Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.Nature Genetics|July 20, 2010
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32Lucia Conde, Eran Halperin, Nicholas K Akers, et al.Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.Pageof 18